Market Insights Health Pharmacies OTC Products

Skin Treatment (Pharmacies) - Poland

Poland

Revenue in the Skin Treatment market is projected to reach €329.40m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 9.35%, resulting in a market volume of €515.00m by 2029.
In global comparison, most revenue will be generated in the United States (€3,045.00m in 2024).
In relation to total population figures, per person revenues of €8.19 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Skin Treatment (Pharmacies) market in Poland has been experiencing steady growth in recent years, driven by changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Skin Treatment (Pharmacies) market in Poland have shifted towards natural and organic products. Consumers are becoming increasingly conscious of the ingredients used in skincare products and are actively seeking out products that are free from harmful chemicals and artificial additives. This shift in preferences has led to an increase in demand for natural and organic skin treatment products, which are often available at pharmacies. One of the key trends in the Skin Treatment (Pharmacies) market in Poland is the rising popularity of anti-aging products. As the population ages, there is a growing demand for skincare products that target signs of aging such as wrinkles, fine lines, and age spots. Pharmacies in Poland have responded to this trend by offering a wide range of anti-aging products, including serums, creams, and masks, that are specifically formulated to address these concerns. Another trend in the market is the increasing demand for skincare products that offer multiple benefits. Consumers are looking for products that not only moisturize and nourish the skin but also provide additional benefits such as sun protection, anti-pollution properties, and brightening effects. This trend has led to the development of skincare products that combine multiple functions, such as moisturizers with SPF and serums with brightening ingredients. In addition to changing customer preferences and emerging trends, there are also local special circumstances that are driving the growth of the Skin Treatment (Pharmacies) market in Poland. Pharmacies in Poland are highly trusted by consumers as a source of reliable and high-quality skincare products. This trust in pharmacies as a distribution channel has contributed to the growth of the market, as consumers prefer to purchase their skincare products from reputable and knowledgeable sources. Underlying macroeconomic factors, such as the increasing disposable income and improving standards of living in Poland, have also played a role in the development of the Skin Treatment (Pharmacies) market. As consumers have more disposable income, they are willing to spend more on skincare products and invest in their personal well-being. This has created a favorable environment for the growth of the market, as consumers are more willing to purchase higher-end and premium skincare products. Overall, the Skin Treatment (Pharmacies) market in Poland is developing in response to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The market is expected to continue growing in the coming years as consumers become more conscious of their skincare routines and seek out products that cater to their specific needs and preferences.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.